May 6, 2014

Health sciences digest: Drug pricing uproar, antioxidant dangers

UW Health Sciences/UW Medicine

The latest news from the UW Health Sciences and UW Medicine:

 

What price for a cure? The economics of drug pricing

The uproar against the $1,000-a-pill hepatitis C drug Sovaldi, generic name sofosbuvir, may signal a turning point in drug pricing in the United States.  Purchasers appear to be pushing back and saying, “No.”  In a Q & A in HSNewsbeat, Sean Sullivan, professor of pharmacy and health services, explains how drug prices are set and changing attitudes on what purchasers are willing to pay.  Read what he has to say:

http://hsnewsbeat.uw.edu/story/what-price-cure-economics-drug-pricing

 

Selenium, Vitamin E heighten prostate cancer risk

Some men who take high doses of selenium and vitamin E supplements could increase their risk of aggressive prostate cancer, according to a recent study led by Alan Kristal, professor of epidemiology. Learn more about the potential downside of  taking these antioxidants:

http://hsnewsbeat.uw.edu/story/study-selenium-vitamin-e-heighten-prostate-cancer-risk

 

Tagged with: , ,